


IMAC Holdings Receives FDA Authorization to Initiate Clinical Study of Its Umbilical Cord-Derived Allogenic Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
BRENTWOOD, Tenn., August 5, 2020 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: IMAC) (the “Company” or “IMAC”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery...
Bone-on-Bone Knees? IMAC Explains Non-Surgical Knee Treatments for Osteoarthritis
Bone-on-Bone Knee Osteoarthritis Treatment Explained Are your knees feeling stiff? Are you having problem rolling over in bed, getting in and out of the car, or struggling going up or down stairs? It could be osteoarthritis of the knee and decreased joint space. When...
Recent Comments